Vaccination against the feline immunodeficiency virus: The road not taken

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 31, Issue 2-3, 2008, Pages 167-190

  Lecollinet, Sylvie ^a   Richardson, Jennifer ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Feline immunodeficiency virus; Vaccination

Indexed keywords

ADJUVANT; CYTOKINE; DNA; FEL O VAX FIV; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VACCINE; ISCOM; LIVE VACCINE; PLASMID DNA; RECOMBINANT VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAT; CLINICAL FEATURE; DOMESTIC ANIMAL; DRUG DESIGN; FELINE IMMUNODEFICIENCY VIRUS; HOST; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; VACCINATION; VIRUS INFECTION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 39849090162     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.07.007     Document Type: Article

References (122)

1. S.P. Dunham Lessons from the cat: development of vaccines against lentiviruses Vet Immunol Immunopathol 112 1–2 2006 67 77
2. N.C. Pedersen E.W. Ho M.L. Brown J.K. Yamamoto Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome Science 235 4790 1987 790 793
3. T. Miyazawa K. Tomonaga Y. Kawaguchi T. Mikami The genome of feline immunodeficiency virus Arch Virol 134 3–4 1994 221 234
4. M.C. Gemeniano E.T. Sawai E.E. Sparger Feline immunodeficiency virus ORF-A localizes to the nucleus and induces cell cycle arrest Virology 325 2 2004 167 174
5. R.A. Olmsted V.M. Hirsch R.H. Purcell P.R. Johnson Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses Proc Natl Acad Sci USA 86 20 1989 8088 8092
6. E.B. Stephens E. Monck K. Reppas E.J. Butfiloski Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation J Virol 65 3 1991 1114 1123
7. D.L. Lerner P.C. Wagaman T.R. Phillips Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase Proc Natl Acad Sci USA 92 16 1995 7480 7484
8. M. Shimojima T. Miyazawa Y. Ikeda Use of CD134 as a primary receptor by the feline immunodeficiency virus Science 303 5661 2004 1192 1195
9. A. de Parseval U. Chatterji P. Sun J.H. Elder Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor Proc Natl Acad Sci USA 101 35 2004 13044 13049
10. Q.J. Sattentau J.P. Moore F. Vignaux F. Traincard P. Poignard Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding J Virol 67 12 1993 7383 7393
11. J. Richardson G. Pancino R. Merat Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus J Virol 73 5 1999 3661 3671
12. A. de Parseval U. Chatterji G. Morris P. Sun A.J. Olson J.H. Elder Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus Nat Struct Mol Biol 12 1 2005 60 66
13. B.J. Willett L. Picard M.J. Hosie J.D. Turner K. Adema P.R. Clapham Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses J Virol 71 9 1997 6407 6415
14. M. Bendinelli M. Pistello S. Lombardi Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen Clin Microbiol Rev 8 1 1995 87 112
15. G.A. Dean G.H. Reubel P.F. Moore N.C. Pedersen Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node J Virol 70 8 1996 5165 5169
16. R.V. English C.M. Johnson D.H. Gebhard M.B. Tompkins In vivo lymphocyte tropism of feline immunodeficiency virus J Virol 67 9 1993 5175 5186
17. C. Novotney R.V. English J. Housman Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus AIDS 4 12 1990 1213 1218
18. M.J. Burkhard G.A. Dean Transmission and immunopathogenesis of FIV in cats as a model for HIV Curr HIV Res 1 1 2003 15 29
19. A.L. Guiot D. Rigal G. Chappuis Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: cellular targets and modulation Vet Immunol Immunopathol 58 2 1997 93 106
20. J.N. Flynn P. Keating M.J. Hosie Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination J Immunol 157 8 1996 3658 3665
21. G. Pancino C. Chappey W. Saurin P. Sonigo B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins J Virol 67 2 1993 664 672
22. S. Lombardi M. Bendinelli C. Garzelli Detection of B epitopes on the p24 gag protein of feline immunodeficiency virus by monoclonal antibodies AIDS Res Hum Retroviruses 9 2 1993 141 146
23. K. Matsuo Y. Nishino T. Kimura Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses J Gen Virol 73 Part 9 1992 2445 2450
24. J.N. Flynn J.A. Beatty C.A. Cannon Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus AIDS Res Hum Retroviruses 11 9 1995 1107 1113
25. S. Lombardi C. Garzelli C. La Rosa Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope J Virol 67 8 1993 4742 4749
26. J. Richardson I. Fossati A. Moraillon S. Castelot P. Sonigo G. Pancino Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope J Gen Virol 77 Part 4 1996 759 771
27. O. Hartley P.J. Klasse Q.J. Sattentau J.P. Moore V3: HIV's switch-hitter AIDS Res Hum Retroviruses 21 2 2005 171 189
28. S. Broche-Pierre J. Richardson A. Moraillon P. Sonigo Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties J Gen Virol 86 Part 9 2005 2495 2506
29. G. Pancino H. Ellerbrok M. Sitbon P. Sonigo Conserved framework of envelope glycoproteins among lentiviruses Curr Top Microbiol Immunol 188 1994 77 105
30. J.A. Beatty B.J. Willett E.A. Gault O. Jarrett A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction J Virol 70 9 1996 6199 6206
31. W. Song E.W. Collisson P.M. Billingsley W.C. Brown Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats J Virol 66 9 1992 5409 5417
32. Y. Inoshima Y. Ikeda M. Kohmoto Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus J Vet Med Sci 58 9 1996 925 927
33. J.N. Flynn C.A. Cannon D. Sloan J.C. Neil O. Jarrett Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes Immunology 96 2 1999 220 229
34. T. Hohdatsu M. Okubo H. Koyama Feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus activity mediated by a soluble factor(s) J Gen Virol 79 Part 11 1998 2729 2735
35. I.S. Choi R. Hokanson E.W. Collisson Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication J Virol 74 2 2000 676 683
36. J.A. Levy C.E. Mackewicz E. Barker Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells Immunol Today 17 5 1996 217 224
37. J.N. Flynn S. Dunham A. Mueller C. Cannon O. Jarrett Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection Vet Immunol Immunopathol 85 3–4 2002 159 170
38. L. Zaccaro M.L. Falcone S. Silva Defective natural killer cell cytotoxic activity in feline immunodeficiency virus-infected cats AIDS Res Hum Retroviruses 11 6 1995 747 752
39. Y. Liang L.C. Hudson J.K. Levy J.W. Ritchey W.A. Tompkins M.B. Tompkins T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats J Infect Dis 181 2 2000 564 575
40. J.G. Bucci D.H. Gebhard T.A. Childers R.V. English M.B. Tompkins W.A. Tompkins The CD8+ cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 beta chain J Infect Dis 178 4 1998 968 977
41. R. Paillot S. Richard F. Bloas Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders Vet Immunol Immunopathol 106 1–2 2005 1 14
42. J.V. Giorgi L.E. Hultin J.A. McKeating Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage J Infect Dis 179 4 1999 859 870
43. S. Kaushik M. Vajpayee V. Sreenivas P. Seth Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients Clin Immunol 119 3 2006 330 338
44. S.E. Langford J. Ananworanich D.A. Cooper Predictors of disease progression in HIV infection: a review AIDS Res Ther 4 1 2007 11
45. A.M. Cuisinier V. Mallet A. Meyer C. Caldora A. Aubert DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus Vaccine 15 10 1997 1085 1094
46. A.M. Cuisinier A. Meyer B. Chatrenet A.S. Verdier A. Aubert Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection Vaccine 17 5 1999 415 425
47. S.P. Dunham J. Bruce S. MacKay M. Golder O. Jarrett J.C. Neil Limited efficacy of an inactivated feline immunodeficiency virus vaccine Vet Rec 158 16 2006 561 562
48. S. Giannecchini P. Isola O. Sichi AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts J Virol 76 14 2002 6882 6892
49. M.J. Hosie R. Osborne G. Reid J.C. Neil O. Jarrett Enhancement after feline immunodeficiency virus vaccination Vet Immunol Immunopathol 35 1–2 1992 191 197
50. W. Huisman J.A. Karlas K.H. Siebelink Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection Vaccine 16 2–3 1998 181 187
51. J.A. Karlas K.H. Siebelink M.A. Peer W. Huisman G.F. Rimmelzwaan A.D. Osterhaus Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells Vet Immunol Immunopathol 65 2–4 1998 353 365
52. J.A. Karlas K.H. Siebelink M.A. Peer Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection J Gen Virol 80 Part 3 1999 761 765
53. M. Pistello F. Bonci J.N. Flynn AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens J Virol 80 18 2006 8856 8868
54. J. Richardson A. Moraillon S. Baud A.M. Cuisinier P. Sonigo G. Pancino Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope J Virol 71 12 1997 9640 9649
55. K.H. Siebelink E. Tijhaar R.C. Huisman Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines J Virol 69 6 1995 3704 3711
56. J. Richardson S. Broche S. Baud Lymphoid activation: a confounding factor in AIDS vaccine development? J Gen Virol 83 Part 10 2002 2515 2521
57. S.P. Dunham J. Bruce D. Klein Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus Vaccine 24 49–50 2006 7095 7108
58. S. VandeWoude C. Apetrei Going wild: lessons from naturally occurring T-lymphotropic lentiviruses Clin Microbiol Rev 19 4 2006 728 762
59. M.A. Curran S.M. Kaiser P.L. Achacoso G.P. Nolan Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors Mol Ther 1 1 2000 31 38
60. K. Kurosawa Y. Ikeda T. Miyazawa Development of restriction fragment-length polymorphism method to differentiate five subtypes of feline immunodeficiency virus Microbiol Immunol 43 8 1999 817 820
61. D.L. Sodora E.G. Shpaer B.E. Kitchell S.W. Dow E.A. Hoover J.I. Mullins Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns J Virol 68 4 1994 2230 2238
62. M.T. Kyaw-Tanner W.K. Greene H.S. Park W.F. Robinson The induction of in vivo superinfection and recombination using feline immunodeficiency virus as the model Arch Virol 138 3–4 1994 261 271
63. S. Okada R. Pu E. Young W.V. Stoffs J.K. Yamamoto Superinfection of cats with feline immunodeficiency virus subtypes A and B AIDS Res Hum Retroviruses 10 12 1994 1739 1746
64. M.H. Bachmann C. Mathiason-Dubard G.H. Learn Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades J Virol 71 6 1997 4241 4253
65. D. Del Mauro D. Matteucci S. Giannecchini F. Maggi M. Pistello M. Bendinelli Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates J Virol 72 3 1998 2199 2207
66. S. Finerty C.R. Stokes T.J. Gruffydd-Jones Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge Vaccine 18 28 2000 3254 3265
67. S. Finerty C.R. Stokes T.J. Gruffydd-Jones T.J. Hillman F.J. Barr D.A. Harbour Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus Vaccine 20 1–2 2001 49 58
68. R. Stevens K.E. Howard S. Nordone M. Burkhard G.A. Dean Oral immunization with recombinant Listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus J Virol 78 15 2004 8210 8218
69. C.R. Stokes S. Finerty T.J. Gruffydd-Jones C.P. Sturgess D.A. Harbour Mucosal infection and vaccination against feline immunodeficiency virus J Biotechnol 73 2–3 1999 213 221
70. H. Kusuhara T. Hohdatsu M. Okumura Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats Vet Microbiol 108 3–4 2005 155 165
71. D. Matteucci A. Poli P. Mazzetti Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats J Virol 74 23 2000 10911 10919
72. M.J. Hosie J.A. Beatty Vaccine protection against feline immunodeficiency virus: setting the challenge Aust Vet J 85 1–2 2007 5 12
73. W. Hesselink P. Sondermeijer H. Pouwels E. Verblakt C. Dhore Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge Vet Microbiol 69 1–2 1999 109 110
74. A.D. Osterhaus E. Tijhaar R.C. Huisman Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus AIDS Res Hum Retroviruses 12 5 1996 437 441
75. C.M. Leutenegger R. Hofmann-Lehmann E. Holznagel Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins AIDS Res Hum Retroviruses 14 3 1998 275 283
76. H. Lutz R. Hofmann-Lehmann K. Bauer-Pham FIV vaccine studies I. Immune response to recombinant FIV env gene products and outcome after challenge infection Vet Immunol Immunopathol 46 1–2 1995 103 113
77. H. Lutz R. Hofmann-Lehmann C. Leutenegger Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection AIDS Res Hum Retroviruses 12 5 1996 431 433
78. M.J. Hosie T.H. Dunsford A. de Ronde Suppression of virus burden by immunization with feline immunodeficiency virus env protein Vaccine 14 5 1996 405 411
79. S. Lombardi C. Garzelli M. Pistello A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity J Virol 68 12 1994 8374 8379
80. J. Richardson A. Moraillon F. Crespeau S. Baud P. Sonigo G. Pancino Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus J Virol 72 3 1998 2406 2415
81. J.N. Flynn C.A. Cannon G. Reid M.A. Rigby J.C. Neil O. Jarrett Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain Immunology 85 2 1995 171 175
82. E.J. Verschoor M.J. Willemse J.G. Stam Evaluation of subunit vaccines against feline immunodeficiency virus infection Vaccine 14 4 1996 285 289
83. J.N. Flynn C.A. Cannon J.C. Neil O. Jarrett Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection J Virol 71 10 1997 7586 7592
84. E.J. Tijhaar W. Huisman R.C. Huisman Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus J Gen Virol 78 Part 12 1997 3265 3275
85. F.S. Boretti C.M. Leutenegger C. Mislin Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression AIDS 14 12 2000 1749 1757
86. C.M. Leutenegger F.S. Boretti C.N. Mislin Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif J Virol 74 22 2000 10447 10457
87. M.J. Hosie J.N. Flynn M.A. Rigby DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies J Virol 72 9 1998 7310 7319
88. M.J. Hosie T. Dunsford D. Klein Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus J Virol 74 20 2000 9403 9411
89. J.N. Flynn M.J. Hosie M.A. Rigby Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination Vaccine 18 11–12 2000 1118 1132
90. S.P. Dunham J.N. Flynn M.A. Rigby Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18 Vaccine 20 11–12 2002 1483 1496
91. K.M. Lockridge M. Chien G.A. Dean Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA Virology 273 1 2000 67 79
92. S. Gupta C.M. Leutenegger G.A. Dean J.D. Steckbeck K.S. Cole E.E. Sparger Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon J Virol 81 2 2007 465 473
93. E.J. Tijhaar K.H. Siebelink J.A. Karlas M.C. Burger F.R. Mooi A.D. Osterhaus Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein Vaccine 15 6–7 1997 587 596
94. M.C. Tellier R. Pu D. Pollock Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats AIDS 12 1 1998 11 18
95. P. Gonin A. Fournier W. Oualikene A. Moraillon M. Eloit Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus Vet Microbiol 45 4 1995 393 401
96. J.K. Yamamoto T. Okuda C.D. Ackley Experimental vaccine protection against feline immunodeficiency virus AIDS Res Hum Retroviruses 7 11 1991 911 922
97. J.K. Yamamoto T. Hohdatsu R.A. Olmsted Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus J Virol 67 1 1993 601 605
98. M.J. Hosie R. Osborne J.K. Yamamoto J.C. Neil O. Jarrett Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines J Virol 69 2 1995 1253 1255
99. M.J. Hosie J.N. Flynn Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection J Virol 70 11 1996 7561 7568
100. M.J. Hosie D. Klein J.M. Binley Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env J Virol 79 3 2005 1954 1957
101. R. Pu J. Coleman M. Omori Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates AIDS 15 10 2001 1225 1237
102. R. Pu J. Coleman J. Coisman Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate J Feline Med Surg 7 1 2005 65 70
103. T. Hohdatsu S. Okada K. Motokawa C. Aizawa J.K. Yamamoto H. Koyama Effect of dual-subtype vaccine against feline immunodeficiency virus infection Vet Microbiol 58 2–4 1997 155 165
104. E.J. Verschoor A.L. van Vliet H.F. Egberink Vaccination against feline immunodeficiency virus using fixed infected cells Vet Immunol Immunopathol 46 1–2 1995 139 149
105. D. Matteucci M. Pistello P. Mazzetti Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies J Virol 70 1 1996 617 622
106. D. Matteucci M. Pistello P. Mazzetti Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted J Virol 71 11 1997 8368 8376
107. S. Giannecchini P. Isola O. Sichi AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts J Virol 76 14 2002 6882 6892
108. M. Kohmoto T. Miyazawa E. Sato Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant Arch Virol 143 9 1998 1839 1845
109. S. VandeWoude C.A. Hageman S.J. O’Brien E.A. Hoover Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus J Acquir Immune Defic Syndr 29 1 2002 1 10
110. M. Pistello D. Matteucci G. Cammarota Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats J Virol 73 2 1999 1518 1527
111. M. Pistello D. Matteucci F. Bonci AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine J Virol 77 20 2003 10740 10750
112. M. Pistello F. Bonci P. Isola Evaluation of feline immunodeficiency virus ORF-a mutants as candidate attenuated vaccine Virology 332 2 2005 676 690
113. W.C. Koff P.R. Johnson D.I. Watkins HIV vaccine design: insights from live attenuated SIV vaccines Nat Immunol 7 1 2006 19 23
114. M. Omori R. Pu T. Tanabe Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine Vaccine 23 3 2004 386 398
115. S. Giannecchini D. Del Mauro D. Matteucci M. Bendinelli AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies J Virol 75 9 2001 4424 4429
116. P. Mazzetti S. Giannecchini D. Del Mauro AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine J Virol 73 1 1999 1 10
117. E.J. Stott Anti-cell antibody in macaques Nature 353 6343 1991 393
118. P.C. Crawford J.K. Levy New challenges for the diagnosis of feline immunodeficiency virus infection Vet Clin North Am Small Anim Pract 37 2 2007 335 350
119. J. Stott N. Almond Assessing animal models of AIDS Nat Med 1 4 1995 295 297
120. Sonigo P, personal communication.
121. R.A. Weiss How does HIV cause AIDS? Science 260 5112 1993 1273 1279
122. G. Pancino I. Fossati C. Chappey Structure and variations of feline immunodeficiency virus envelope glycoproteins Virology 192 2 1993 659 662